Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 0.8001 Delayed Data As of Mar 28 |  -0.009 / -1.11%Today’s Change | 0.53 Today|||52-Week Range 1.82 | +38.07% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 221.3M | 222.2M | 70.5M | 154.9M | |
| Short Term Investment Cash | 61.9M | 822.0K | -151.7M | 85.4M | ||
| Cash & Short Term Investments | 259.1M | 222.2M | 190.5M | 205.1M | ||
| Receivables | Receivables | 449.0K | 886.0K | 0.00 | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 1.5M | 2.2M | 3.3M | 3.7M | |
| Current Assets | 261.0M | 225.3M | 193.7M | 208.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 4.2M | 6.8M | 7.7M | 10.0M | |
| Depreciation | -991.0K | -2.6M | -4.7M | -6.4M | ||
| Intangible Assets | -- | 5.0M | 5.0M | 0.00 | ||
| Other Assets | 140.0K | 5.1M | 5.1M | 156.0K | ||
| Total Assets | 264.3M | 234.6M | 201.9M | 213.5M | ||
| Liabilities | Accounts Payable | 605.0K | 1.5M | 1.7M | 1.7M | |
| Accrued Expenses | 1.9M | 3.8M | 4.6M | 4.4M | ||
| Other Current Liabilities | 3.9M | 5.9M | 6.7M | 6.1M | ||
| Other Liabilities | 6.6M | 9.9M | 10.7M | 10.7M | ||
| Total Liabilities | Deferred Taxes | 0.00 | -1.3M | -1.3M | 0.00 | |
| Other Liabilities | 447.0K | 738.0K | 703.0K | 1.6M | ||
| Total Liabilities | 11.7M | 19.0M | 17.9M | 12.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 252.6M | 215.6M | 184.0M | 201.2M | ||
| Total Shareholder Equity | 252.6M | 215.6M | 184.0M | 201.2M | ||
| Share Information | Common Shares Outstanding | 25.9M | 41.8M | 49.0M | 63.0M | |
| Addtl. Info. | No data currently available for this section. | |||||
